Spenta International has closed its trading window for all designated persons effective July 1, 2026, to comply with insider trading regulations ahead of its quarterly financial results. The window will remain shut until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This restriction prohibits designated persons and their immediate relatives from trading in the company's securities during this period.

The closure follows the provisions of the SEBI (Prohibition of Insider Trading) Regulations, 2015 and the company's Code of Conduct for the prevention of insider trading. The move ensures that no insider trading occurs while the company is in possession of unpublished price-sensitive information related to its financial performance for Q1FY27.

Key Dates and Restrictions

The company has outlined specific timelines for the closure and the associated board meeting. The table below summarizes the critical dates and the applicable restrictions for designated persons.

Designated persons are strictly prohibited from entering into any transaction involving the dealing or trading of the company's securities during the aforesaid period of closure. The date of the board meeting for the consideration and approval of the unaudited financial results will be intimated in due course.

The intimation was submitted to BSE Limited by Danny Firoze Hansotia, Managing Director & CFO, on June 23, 2026.

Spenta International reported a net loss of ₹130.47 lakh for the financial year ended March 31, 2026, reversing the net profit of ₹121.49 lakh recorded in the previous year. Revenue from operations for the year stood at ₹4126.04 lakh, a decrease from ₹4763.84 lakh in FY25. The company's total expenses for the year were ₹4413.81 lakh, slightly lower than the ₹4714.52 lakh reported in the prior year. In compliance with Regulation 30 and 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company submitted copies of the newspaper advertisement of its audited standalone financial results to BSE Limited on June 01, 2026. The results were published in The Free Press Journal (English) and Navshakti (Marathi).

For the quarter ended March 31, 2026, the company reported a net loss of ₹115.52 lakh, compared to a net profit of ₹12.99 lakh in the same quarter of the previous year. Revenue from operations for the quarter increased to ₹1119.57 lakh from ₹982.83 lakh in Q4FY25. Total expenses for the quarter rose to ₹1289.07 lakh from ₹992.91 lakh in the corresponding period last year.

The Board of Directors approved the audited standalone financial results for the quarter and financial year ended March 31, 2026, at a meeting held on May 29, 2026. M/s A K Kocchar & Associates, Chartered Accountants, audited the results and issued an unmodified opinion. The statutory auditors confirmed that the financial results give a true and fair view in conformity with the recognition and measurement principles laid down in the applicable accounting standards. The submission to BSE was signed by Danny Hansotia, Managing Director & CFO of Spenta International.

In addition to the financial results, the Board approved the appointment of M/s B. G. Dolar & Co. Chartered Accountants as internal auditors for FY 2026-2027. The appointment was made pursuant to Regulation 30 of the SEBI (LODR) Regulations, 2015. The firm has no existing relationship with the directors or key managerial personnel of the company.

Financial Results for FY26

The following table summarizes the standalone audited financial results for Spenta International for the year ended March 31, 2026:

Newspaper Publication Details

The following table summarizes the newspaper publication submission made by Spenta International to BSE:

Earnings Per Share

The company reported a basic and diluted earnings per share (EPS) of -₹4.72 for FY26, compared to ₹4.39 in the previous year. For the quarter ended March 31, 2026, the basic and diluted EPS stood at -₹4.18, down from ₹0.47 in the corresponding quarter of the previous year.